Margioula-Siarkou Chrysoula, Almperi Emmanouela-Aliki, Almperis Aristarchos, Margioula-Siarkou Georgia, Titilas Georgios, Dinas Konstantinos, Petousis Stamatios
2nd Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, Ippokrateio General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Cureus. 2024 Nov 26;16(11):e74547. doi: 10.7759/cureus.74547. eCollection 2024 Nov.
Ovarian squamous cell carcinoma (SCC) is a rare entity among primary ovarian cancers. This type of cancer typically originates from the transformation of mature cystic teratomas, commonly known as dermoid cysts, and occasionally from associations with endometriosis or Brenner's tumors. The typical clinical scenario involves presentation in postmenopausal women, with symptoms arising from tumor growth or metastasis. Herein, we present a case study of SCC arising from a dermoid cyst in the right ovary. Alongside this, we offer a concise review covering the histogenesis, diagnostic approaches, current therapeutic modalities, and prognosis associated with this condition. A 62-year-old woman presented with abdominal pain and fever. Imaging revealed a large mass originating from the right ovary, suspected to be ovarian serous cystadenocarcinoma. Elevated CA 19-9 levels indicated malignancy. The case was discussed in a multidisciplinary tumor board (MTB), leading to diagnostic laparoscopy. Despite initial biopsy results suggesting no malignancy, PET-CT indicated possible ovarian malignancy. Further exploration via exploratory laparotomy confirmed the malignancy through fast-track biopsy. As a result, intraoperatively, a primary debulking surgery was decided. The final diagnosis was primary moderately differentiated squamous ovarian carcinoma, stage IIB, originating from a dermoid cyst. The patient was referred for chemotherapy and is currently under follow-up care. This case underscores the complexity of ovarian cancer diagnosis and the importance of multidisciplinary approaches in treatment decisions. As of now, there are no established treatment guidelines for the effective management of this histotype. More research specifically tailored to this aim, involving global contribution and extended follow-up periods, are essential to establish the best management strategies.
卵巢鳞状细胞癌(SCC)在原发性卵巢癌中是一种罕见的类型。这种癌症通常起源于成熟囊性畸胎瘤(俗称皮样囊肿)的转化,偶尔也起源于与子宫内膜异位症或勃勒纳瘤相关的情况。典型的临床情况是在绝经后女性中出现,症状由肿瘤生长或转移引起。在此,我们呈现一例源自右侧卵巢皮样囊肿的SCC病例研究。同时,我们提供了一篇简短综述,涵盖了这种疾病的组织发生、诊断方法、当前治疗方式以及预后。一名62岁女性出现腹痛和发热。影像学检查发现一个起源于右侧卵巢的大肿块,怀疑是卵巢浆液性囊腺癌。CA 19 - 9水平升高提示恶性肿瘤。该病例在多学科肿瘤委员会(MTB)中进行了讨论,随后进行了诊断性腹腔镜检查。尽管最初的活检结果提示无恶性肿瘤,但PET - CT显示可能存在卵巢恶性肿瘤。通过剖腹探查进一步检查,经快速活检确诊为恶性肿瘤。因此,术中决定进行初次肿瘤细胞减灭术。最终诊断为原发性中度分化的卵巢鳞状细胞癌,IIB期,起源于皮样囊肿。该患者被转诊接受化疗,目前正在接受随访。这个病例强调了卵巢癌诊断的复杂性以及多学科方法在治疗决策中的重要性。目前,对于这种组织学类型的有效管理尚无既定的治疗指南。针对这一目标进行更具体的研究,包括全球范围内的参与和更长的随访期,对于确立最佳管理策略至关重要。